Registration Updates: Bioperfectus COVID-19 Self Ag Test is Now Available in Spain

Company news
2022-02-05

Bioperfectus today solemnly announce that Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit (Self-test) has been entered in the electronic registry of the Agencia Española de Medicamentos y Productos Sanitarios (Spanish Agency for Medicines and Health Products, AEMPS). This registration symbolizes that our COVID-19 Self-test product is now officially available in the local Spain market.

 

Inquiry of the product, please send us an email to info@bioperfectus.com.

MOST READ

Bioperfectus Supports Cholera Elimination

SHANGHAI, CHINA, December 5, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”) is pleased to launch Vibrio Cholerae Real Time PCR Kits for human diagnosis and early warning surveillance.

2022-11-30

Client Story: A Race Against Time

Through a critical assessment of clinical evaluation and data validation, Bioperfetus successfully passed the Israeli ministry of health inspection. Bioperfetus was the only Chinese company on the procurement list and was asked to provide one million antigen rapid test kits for the Israeli ministry of health.

2022-11-15

Bioperfectus Granted MDA Approval in Malaysia for Nucleic Acid Extraction Systems

SHANGHAI, CHINA, November 14, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”), a leading global company in the molecular diagnostics market, today announced receipt of MDA (Medical Device Authority) approval in Malaysia for Nucleic Acid Extraction Systems, including Nucleic Acid SSNP-2000B, SSNP-3000A, SSNP-9600A, SMPE-960 and Extraction Rapid Kit (Magnetic Bead Method).

2022-11-14